Monday, December 29, 2014 Last update: 5:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Marken Appoints Paul J. Rice To Head EMEA Region

Companies mentioned in this article: Marken

RESEARCH TRIANGLE PARK, N.C., July 8, 2014 /PRNewswire/ -- Marken announced today the appointment of Paul J. Rice as Vice President, Logistics, EMEA Region. Mr. Rice will be based in London but will have responsibility for the branches and associated business in Europe and Africa including: Paris, London, Edinburgh, Frankfurt, Brussels, Stockholm, Zurich and Johannesburg.

http://photos.prnewswire.com/prnvar/20110930/NY78064LOGO

Mr. Rice brings 23 years of relevant experience including senior roles in logistics and supply chain within the healthcare and life sciences markets. He joins Marken from Alliance Boots where he served as Commercial Director for Europe. Prior to his role at Alliance Boots, he was Executive Director for EMEA Distribution and Logistics at Merck & Co. which followed ten years in various roles at DHL / Exel. He has extensive international experience throughout the world including the EMEA region but also in Asia and the United States. Mr. Rice holds a BS degree in Engineering and a Masters degree in Business Administration.

Wes Wheeler, Marken's Chief Executive Officer, commented on the appointment, "Paul will be a great addition to the Marken family. He brings deep experience to our team not only in logistics, but also from his various roles working with clinical supplies and commercial drug product. By having Paul in place and leading the EMEA region, we can expand our reach, lead with strength and continue to provide excellent service for our healthcare clients. We look forward to Paul joining us at the end of this month."

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.

SOURCE Marken